home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Competitive T Cells Strip Antigen-Presenting Cells In Vivo

  December, 3 2001 9:29
your information resource in human molecular genetics
Like any competitive sport, your immune system needs to field its best players in order to win the match against pathogens. Investigators report in the January issue of Nature Immunology that T cells aggressively compete with one another for access to the bits of antigen sitting on "antigen-presenting cells". This struggle ultimately benefits the host, as only the most effective T cells survive, honing the immune response to a fine point in the hopes of "tipping the scales" against the foreign invaders.

Ross Kedl, working with Pippa Marrack and colleagues at the National Jewish Medical Research Center in Denver, shows that when T cells with a range of abilities to bind antigens are vying for access to antigen-presenting cells, only the T cells with the best binding get much "face time". These "high-affinity" T cells dominate the antigen-presenting cells, virtually excluding the lower-affinity T cells. And part of the strategic plan entails the stripping of antigen from the surface of the presenting cell, thus making interactions with lower affinity T cells almost impossible. It's this type of competition that leads to consistently better immune responses - and good immunization.

Author contact:
Ross M. Kedl
3M Pharmaceuticals
St Paul, MN
Tel: +1 651 733 4821
E-mail: rmkedl@mmm.com

Additional contact for comment on paper:
Antonio Lanzavecchia
Institute for Research in Biomedicine
Bellinzona, Switzerland
Tel: +41 91 820 0300
E-mail: lanzavecchia@irb.unisi.ch

(C) Nature Immunology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.